Trials / Completed
CompletedNCT03600519
Retinal Imaging Using NOTAL-OCT V2.5
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Notal Vision Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary objectives: To compare between retinal measurements, done by the NOTAL-OCT V2.5 device and a commercial OCT. Secondary objectives: 1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula. 2. To evaluate the repeatability of the NOTAL-OCT V2.5
Detailed description
Study population: 1. AMD population - intermediate and advanced AMD (with active and nonactive CNV) 2. DR population. Patient with and without DME
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NOTAL OCT V2.5 | AMD Patients |
Timeline
- Start date
- 2018-07-22
- Primary completion
- 2019-02-18
- Completion
- 2020-01-01
- First posted
- 2018-07-26
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03600519. Inclusion in this directory is not an endorsement.